Structured Summary
Abstract
A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
15 entry terms
- Enbrel
- Erelzi
- Etanercept-szzs
- Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein
- TNF Receptor Type II-IgG Fusion Protein
- TNFR-Fc Fusion Protein
- TNR 001
- TNR-001
- TNT Receptor Fusion Protein
- TNTR-Fc
- Fusion Protein, TNFR-Fc
- Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein
- TNF Receptor Type II IgG Fusion Protein
- TNFR Fc Fusion Protein
- TNR001
MeSH Record
Aspects Covered
22 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analogs & derivatives, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2016 (1997)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Etanercept. Medical Subject Headings (MeSH). 2026. Unique ID D000068800. http://id.nlm.nih.gov/mesh/2026/D000068800
- Etanercept. In: Wikipedia. https://en.wikipedia.org/wiki/Etanercept
- Etanercept. In: Wikidata. https://www.wikidata.org/wiki/Q415343